Brian Weiss MD

Brian Weiss MD
Research Asst ProfessorCollege of Medicine--UCBrian.Weiss@cchmc.org
MLC R 7015 3333 Burnet Avenue Cincinnati OH 452293039
Phone:513-636-4266Fax: 513-636-3549
  • Non-Member

Current Publications

  • Wagner L, Turpin B, Nagarajan R, Weiss B, Cripe T, Geller JPilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors.Pediatr Blood Cancer 60(9) 1447-51 9/1/2013
  • Scott JR, Courter JD, Saldaña SN, Widemann BC, Fisher M, Weiss B, Perentesis J, Vinks AAPopulation pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1.Ther Drug Monit 35(3) 332-7 6/1/2013
  • Bishop MW, Yin H, Shimada H, Towbin AJ, Miethke A, Weiss BManagement of Stage 4S Composite Neuroblastoma With a MYCN-amplified Nodule.J Pediatr Hematol Oncol in press 3/21/2013
  • Matthay KK, Weiss B, Villablanca JG, Maris JM, Yanik GA, Dubois SG, Stubbs J, Groshen S, Tsao-Wei D, Hawkins R, Jackson H, Goodarzian F, Daldrup-Link H, Panigrahy A, Towbin A, Shimada H, Barrett J, Lafrance N, Babich JDose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.J Nucl Med 53(7) 1155-63 7/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu